A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-Risk Women With Axillary Node-Negative Breast Cancer (NSAS-BC).

Trial Profile

A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-Risk Women With Axillary Node-Negative Breast Cancer (NSAS-BC).

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2016

At a glance

  • Drugs Tegafur/uracil (Primary) ; Cyclophosphamide; Fluorouracil; Methotrexate
  • Indications Breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Feb 2009 Status changed from completed to active, no longer recruiting.
    • 09 Feb 2009 Results were published in the Journal of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top